Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (Clinical trial)

research1
Did you know, that you can look up clinical trials on scleroderma on following sites: https://clinicaltrials.gov/ and https://www.clinicaltrialsregister.eu/

For instance you can find following trial by Genentech:

A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc) [focuSSced]

Official title: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of Tocilizumab Versus Placebo in Patients With Systemic Sclerosis.

The company is looking to enroll 210 patients in the following countries: Argentina, Belgium, Brazil, Bulgaria, Canada, Croatia, Denmark, France, Germany, Greece, Hungary, Italy, Lithuania, Japan, Mexico, Netherlands, Poland, Portugal, Romania, South Africa, Spain, Switzerland, UK, and USA.

Read more here: https://clinicaltrials.gov/ct2/show/NCT02453256?term=focuSSced&rank=1

 

 

Tagged: ,

Comments are closed.

%d bloggers like this: